Miriam Tao

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study.

Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study.

Journal: Leukemia & lymphoma
Published: December 28, 2024

Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell Lymphoma.

Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell Lymphoma.

Journal: Cancers
Published: August 24, 2024

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma.

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma.

Journal: Experimental hematology & oncology
Published: December 15, 2023

Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.

Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.

Journal: Leukemia & lymphoma
Published: July 21, 2023

Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin's Lymphoma.

Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin's Lymphoma.

Journal: Hematology reports
Published: November 19, 2022

Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort study.

Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort study.

Journal: Leukemia & lymphoma
Published: June 10, 2022

A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.

A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.

Journal: Cancers
Published: February 23, 2022

Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy.

Burkitt lymphoma - no impact of HIV status on outcomes with rituximab-based chemoimmunotherapy.

Journal: Leukemia & lymphoma
Published: February 21, 2022

A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

Journal: American journal of hematology
Published: December 13, 2021

Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method.

Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method.

Journal: Leukemia & lymphoma
Published: October 19, 2021

Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma.

Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma.

Journal: Journal of hematology
Published: July 08, 2021

Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.

Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.

Journal: Cancer reports (Hoboken, N.J.)
Published: March 28, 2021
Showing 1-12 of 42

Last Updated: 09/26/2026